7-Fluoro-6-nitro-4-hydroxyquinazoline is a pharmaceutical intermediate for the synthesis of kinase inhibitors, such as ATP Site inhibitors of the Tyrosine Kinase activity of the epidermal growth factor receptor.
Tyrosine Kinase Inhibitors. 9. Synthesis and Evaluation of Fused Tricyclic Quinazoline Analogues as ATP Site Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor.
Structure-based virtual screening of Src kinase inhibitors.
Studying the Conformation of a Receptor Tyrosine Kinase in Solution by Inhibitor-Based Spin Labeling.
 G.W.Rewcastle, et al, J. Med. Chem., 1996, 39(4), pp 918-928.